PLoS ONE · 2021 · 17 citations · 11 references
Life SciencesGeneticsMolecular GeneticsGenome EditingGenomicsPrecision MedicineCrispr-based EngineeringCrispr-cas SystemsMutagenesis StrategiesCrispr DiagnosticsCrispr-based Molecular DiagnosticsCrispr-cas Genome EditingCrispr-cas12 SystemsGenetic Mutation DetectionTargeted Mutation Detection
Many CRISPR/Cas platforms have been established for the detection of SARS-CoV-2. But the detection platform of the variants of SARS-CoV-2 is scarce because its specificity is very challenging to achieve for those with only one or a few nucleotide(s) differences. Here, we report for the first time that chimeric crRNA could be critical in enhancing the specificity of CRISPR-Cas12a detecting of N501Y, which is shared by Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2 without compromising its sensitivity. This strategy could also be applied to detect other SARS-CoV-2 variants that differ only one or a few nucleotide(s) differences.
11
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen, Enbo Ma, Lucas B. Harrington et al. · Science · 2018 · 4.4K citations
CRISPR–Cas12-based detection of SARS-CoV-2
James P. Broughton, Xianding Deng, Guixia Yu et al. · Nature Biotechnology · 2020 · 2.8K citations · Full text
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas, David Veyer, Artem Baidaliuk et al. · Nature · 2021 · 2.2K citations · Full text
SHERLOCK: nucleic acid detection with CRISPR nucleases
Max J. Kellner, Jeremy Koob, Jonathan S. Gootenberg et al. · Nature Protocols · 2019 · 1.6K citations · Full text
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text